Aspirin may help fight aggressive breast cancer by making hard-to-treat tumours more responsive to anti-cancer drugs, doctors say.

A team at the Christie NHS Foundation Trust, in Manchester, are beginning a trial with triple-negative breast-cancer patients.

They suspect it is aspirin’s anti-inflammatory properties rather than its analgesic effect that gives the boost.
Animal studies have already shown encouraging results.

There is some evidence aspirin might help prevent certain other cancers and lower the risk of it spreading. But it is too early to recommend people start taking it. More research is needed. About 8,000 women are diagnosed with triple-negative breast cancer in the UK each year - a less common but often more aggressive type of breast cancer that disproportionately affects younger women and black women.
Source : BBC